gabexate has been researched along with Lung Neoplasms in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Lung Neoplasms: Tumors or cancer of the LUNG.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Uetsuji, S | 1 |
| Yamamura, M | 1 |
| Takai, S | 1 |
| Hioki, K | 1 |
| Yamamoto, M | 1 |
1 other study available for gabexate and Lung Neoplasms
| Article | Year |
|---|---|
Effect of aprotinin on metastasis of Lewis lung tumor in mice.
Topics: Animals; Aprotinin; Cathepsins; Endopeptidases; Gabexate; Kallikreins; Lung Neoplasms; Male; Mice; M | 1992 |